Clinical Trial: Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Phase I Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Administered as Single Bolus Injections or Infusions in Japanese Subjects With

Brief Summary: The trial is an open-label, 4 cohorts, sequential, dose-escalating, single dose trial.